| Session I 第一场 |
|||
| Moderator 主持人 | Jieming Mao 毛节明, Shumei Li 李淑梅, Shisen Jiang 江时森, Guizhou Tao 陶贵周, Shaowei Zhuang 庄少伟 | ||
|
1:30 PM- |
Do We Really Need a More Rapid Onset of P2Y12 Receptor Antagonists in Stable CAD PCI? 稳定性冠心病介入治疗我们真的需要更快速起效的P2Y12受体拮抗剂？ |
Guosheng Fu 傅国胜 | |
|
1:45 PM- |
Anticoagulation Time Limit for Decision Making of Venous Thromboembolism 决策静脉血栓栓塞的抗凝时限 |
Lan Huang 黄岚 | |
|
2:00 PM- |
Optimized Therapy in Elderly CAD Patients 老年冠心病优化治疗 |
Meilin Liu 刘梅林 | |
|
2:15 PM- |
Statin Choice in China 他汀类药物的临床选择：中国医患共同决策研究报告 |
Rongchong Huang 黄榕翀 | |
|
2:30 PM- |
Pay Attention to the Detection of Anticoagulant Drugs 重视抗凝药物的检测 |
Xiangjun Yang 杨向军 | |
|
2:45 PM- |
Advances in Anticoagulation Therapy for Atrial Fibrillation 房颤抗凝治疗进展 |
Xinchun Yang 杨新春 | |
|
3:00 PM- |
Antiplatelet and Anticoagulant Strategy for CAD Patients with Atrial Fibrillation 冠心病合并房颤的抗栓抗凝治疗策略 |
Jiefu Yang 杨杰孚 | |
| Session II 第二场 |
|||
| Moderator 主持人 | Han Lei 雷寒, Hongwei Li 李虹伟, Yi An 安毅, Danqing Yu 余丹青, Xiling Shou 寿锡凌 | ||
|
3:15 PM- |
Errors in Clinical Use of Tirofiban 替罗非班临床使用误区 |
Tongguo Wu 吴同果 | |
|
3:30 PM- |
The Relationship between Epicardial Adipose Tissue and Coronary Artery Disease and Its Mechanism 心外膜脂肪组织与冠心病关系及其机制 |
Yingxin Zhao 赵迎新 | |
|
3:45 PM- |
Characteristics of New Platelet Antagonists in Chinese Population and Related 10 Points of Attention 新型血小板拮抗剂在中国人群应用的特征及相关10点注意问题 |
Yonghong Zhu 朱永宏 | |
|
4:00 PM- |
Evaluation and Intervention of Coronary Microcirculation Function: Current Status and Future Perspective 冠脉微循环功能的评估和干预：现状及展望 |
Chun Liang 梁春 | |
|
4:15 PM- |
Application of New Generation of GP IIb/IIIa Receptor Antagonists Eptifibatide in PCI 新一代GP IIb/IIIa受体拮抗剂依替巴肽在PCI中的应用 |
Zhigang Lu 陆志刚 | |
|
4:30 PM- |
Clinical Issues of HIT and GIT HIT与GIT的临床问题 |
Hongliang Cong 丛洪良 | |
|
4:45 PM- |
Coronary Artery Spasm and Ischemic Heart Disease 冠状动脉痉挛与缺血性心脏病 |
Meng Wei 魏盟 | |
|
5:00 PM- |
Adjourn 休会 |
||